Replies to post #76260 on Biotech Values

[DewDiligence]

VRUS addendum: After dropping Clevudine today, VRUS is effectively a “pure” HCV company. No one should be snookered by VRUS’ bogus claims about its HIV drug, Racevir, which is merely a racemic version of GILD’s Emtriva and is going absolutely nowhere, commercially.